)
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sales declining anyway and there is no need to ban because of alleged misuse, say experts
India accounts for around 26 percent of all head and neck cancer cases globally
Mainly a PPP and B2B player, the Pune-based chain offers disruptive pricing
In India there are between 8-10 million people with heart failure, making it one of the world's largest populations with the malady
First major acquisition by Aman Mehta after taking charge at Torrent Pharma in August
Taking legal advice on next steps to pursue open offer for 26% stake in Fortis
The industry is divided on the issue of phasing out codeine-based cough syrups, which are used by many as intoxicants
CDSCO aims to phase out these combinations and codeine-based drugs in a phased manner
Despite accounting for 46% of hospital empanelments, private hospitals accounted for 54 per cent of 38 million hospital admissions under AB-PMJAY
Candle Partners study shows that from the peak of 30% of gross block in FY16, the capex is down to 9-10% of gross block
Hospitals asked to give 20% discount on MRP of medicines, say term is unviable for them
Some cities like Delhi and Mumbai are also witnessing cases of leptospirosis and gastroenteritis fevers
When the brothers did not pay the arbitral award enforced by the Delhi High Court, Daiichi had filed a special leave petition in the apex court in 2018
Pharma giant Roche believes, its ability to reinvent itself through innovation was behind its success. Business Standard's Sohini Das and Nivedita Mookerji spoke to the members of its founding family
India currently exports Rs. 23,766 crore (2021-22) of medical devices up from previous year Rs 19,736 crore
In December 2019 the decision was revised to allow sale of land to private entities as well through a competitive bidding process
It will recommend 'legally enforceable mechanisms', is expected to give a report in 90 days
'They (the next 125 years) look more challenging than the past 125 years. The world has changed. We have to make quicker decisions'
Allows self declaration on portal for licensing purposes
All Class A and Class B med device makers to switch to licensing regime within; many are dealing with slow pace of govt audits or simply not clearing them